SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Mish's Global Economic Trend Analysis
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TobagoJack who wrote (50521)5/6/2006 9:19:56 AM
From: shades   of 116555
 
US FDA Warns Of Kidney Failure Linked To Bowel Cleansers

.

WASHINGTON (AP)--U.S. federal health officials warned Friday of kidney failure associated with certain products used to cleanse the bowel before colonoscopies and other procedures.

The Food and Drug Administration said in an alert to doctors and patients that it has documented 22 cases of acute phosphate nephropathy, a rare but serious form of kidney failure associated with the use of oral sodium phosphates. The products cleanse the bowel by causing patients to loose large amounts of fluid through bowel movements.

Of the cases, 21 involved patients given solutions such as Fleet Phospho-soda or Fleet Accu-Prep. One patient had taken Visicol tablets. None had taken OsmoPrep tablets, a recently approved oral sodium phosphate product, the FDA said.


On the Net:

Food and Drug Administration: fda.gov


(END) Dow Jones Newswires

May 05, 2006 18:29 ET (22:29 GMT)

Copyright (c) 2006 Dow Jones & Company, Inc.- - 06 29 PM EDT 05-05-06
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News